ABOUT GlobeImmune
NEWSROOM
CAREERS
CONTACT US
INVESTORS
Platform
Product Pipeline
Tarmogen Technology
Cancer
GI-4000 / Mutated Ras
GI-6207 / CEA
GI-6301 / Brachyury
Infectious Disease
GI-5005 / HCV
GI-13020 / HBV
Home
|
Archived Press Releases
|
2012 Press Releases
| GlobeImmune Initiates Phase 1 Clinical Trial of GI-6301 in Brachyury Expressing Cancers
GlobeImmune Initiates Phase 1 Clinical Trial of GI-6301 in Brachyury Expressing Cancers
Print
February 08, 2012
Sorry you have no rights to view this post!
